IJMS | Free Full-Text | Evaluation of Haptoglobin and Its Proteoforms as Glioblastoma Markers
Carbohydrate antigen 19-9 elevation without evidence of malignant or pancreatobiliary diseases | Scientific Reports
Spolehlivost markerů CEA a CA 19-9 při monitoraci výsledků léčby metastatického kolorektálního karcinomu CT vyšetřením » Linkos.cz
Cellulose-based hydrogel on quantum dots with molecularly imprinted polymers for the detection of CA19-9 protein cancer biomarker | SpringerLink
MarkerDB
Ovarian Cancer Tumor Markers
Antygen nowotworowy CA 19-9 - charakterystyka, normy, cel i przebieg badania | WP abcZdrowie
The clinical utility of normal range carbohydrate antigen 19-9 level as a surrogate marker in evaluating response to treatment in pancreatic cancer—a report of two cases - Al-Shamsi - Journal of Gastrointestinal
CA 19-9 tumour-marker response to chemotherapy in patients with advanced pancreatic cancer enrolled in a randomised controlled trial - The Lancet Oncology
Carbohydrate antigen 19-9 — tumor marker: Past, present, and future
The clinical utility of normal range carbohydrate antigen 19-9 level as a surrogate marker in evaluating response to treatment in pancreatic cancer—a report of two cases - Al-Shamsi - Journal of Gastrointestinal
CA 19-9 - normy, cena i badanie. Co oznacza ten marker?
Marker nowotworowy CA 19-9 (antygen nowotworowy 19-9) - Centrum Medyczne Meavita | Kraków, Rusznikarska 14
Cureus | Low Carbohydrate Antigen 19-9 (CA 19-9) Levels in a Patient Highly Suspected of Having Caput Pancreas Tumor | Article
Carbohydrate antigen 19-9 elevation without evidence of malignant or pancreatobiliary diseases | Scientific Reports
Antygen CA 19-9 - kiedy należy wykonać badanie? Jak interpretować wyniki?
Extraordinarily elevated serum levels of CA 19-9 and rapid decrease after succesfull therapy: A case report and review of litera
PDF) Estimating prognosis and palliation based on tumour marker CA 19-9 and quality of life indicators in patients with advanced pancreatic cancer receiving chemotherapy
CA 19-9 – Pancreatic Cancer Action Network
The clinical utility of normal range carbohydrate antigen 19-9 level as a surrogate marker in evaluating response to treatment in pancreatic cancer—a report of two cases - Al-Shamsi - Journal of Gastrointestinal
Comparison of the Normal CA 19-9 Level Group and Elevated CA 19-9 Level... | Download Scientific Diagram
Marker nowotworowy CA 19-9 w diagnostyce nowotworów przewodu pokarmowego - Laboratorium Medyczne badaj.to
Tumour Markers
